M.C. Escher By Way of Generic Drug Pricing (Jan 17, 2019 21:57)
By Sara W. Koblitz —

AdvaMed Updates Code of Ethics (Jan 16, 2019 22:29)
By Serra J. Schlanger & Jeffrey N. Wasserstein —

FDA is “Discouraged” by Dearth of HCT/P Manufacturers that have Reached Out to Agency During Enforcement Discretion Period (Jan 15, 2019 22:31)
By Mark I. Schwartz —

Vermont Report Finds that the Costs of Prescription Drug Importation May Outweigh Savings (Jan 14, 2019 21:08)
By Serra J. Schlanger —

Updated CLIA Waiver Guidances Lack Details in Original Draft (Jan 13, 2019 20:19)
By Allyson B. Mullen —

FDA Solicits Feedback on Grace Period Timing for GUDID Submissions (Jan 10, 2019 21:22)
By Rachael E. Hunt —

What They Said – A Review of FDA Press Statements for 2018 (Jan 10, 2019 00:00)
Periodically it is a good idea to take the pulse of what FDA is saying. This is not by ...

Powered by Feed Informer